Telix Chooses IBA's Cyclone KIUBE for US Expansion

IBA has signed a contract with Telix Pharmaceuticals for the delivery of four Cyclone KIUBE cyclotrons to RLS Radiopharmacies in the US. This investment supports Telix's strategic expansion in the US, enhancing its production capabilities and supply chain resilience. The Cyclone KIUBE 180 cyclotrons will be equipped with the QUANTM Irradiation System, allowing for the production of essential radioisotopes, such as Gallium-68, Zirconium-89, Technetium-99m, and Copper-64. The partnership aims to increase the availability of advanced diagnostic tools and improve patient outcomes.